We use cookies on this site to enhance your user experience. Click here for more information about how we use cookies on our site or read our privacy policy here.
Increasing capacity and yield are valuable in their own right, yet they’re even more powerful together. Strike the right balance and you’ll achieve the required number of doses and a strong ROI.
Advances in new treatments and high demand from across the world have led to rapid growth in the US biopharmaceutical industry.
In order to meet this demand, manufacturers will be looking to invest in people, equipment and new facilities.
Yet increasing or maximizing capacity is not the only option available to manufacturers.
This whitepaper looks at how increasing capacity and improving yield go hand-in-hand – and how biopharma manufacturers benefit from investment in both.
Planning for repeatable precision by identifying the areas Pharma manufacturing can utilize technology to scale up the process and still ensure the maintenance of GMP status.
An overview of the trajectory of pharma production.
This guide explores the cyber security threats faced by pharmaceutical manufacturers in more detail and sets out exactly how to leverage data, without compromising security.
3 ways in which using Excel for production planning is hurting your business
The use of Excel spreadsheets for production planning and scheduling is surprisingly widespread in the manufacturing environment. The software is familiar to many planners, and it can be seen as a quick and easy option when it comes to production scheduling. However, there are sophisticated software solutions are available which could transform the way you manage production planning. Is it time to leave Excel behind?
Read article
Case Study: Orchestrate Puts Biopharma Company on Track to Achieve Growth
Having scaled up significantly, the global pharmaceutical company wanted to maximize capacity and get the most from every batch.
Read case study
Realising the full potential of the UK’s £100m vaccine manufacturing facility
The UK government has invested an extra £100m in a new state-of-the-art centre to scale up Covid-19 vaccine and gene therapy manufacturing. It says this will be vital for the UK’s ability to respond to viruses like the new coronavirus and other potential future pandemics. Rod Schregardus, a pharmaceutical manufacturing expert at The Access Group says this is great news, but warns that consideration must also be given now to the facility’s manufacturing planning and scheduling systems to ensure it can meet its full potential.
Read article
Manufacturing challenges for the pharmaceutical industry
The outbreak has shone a light on the supply chain and its capabilities. With some nations struggling to access the resources needed to manufacture health care products already on the market - let alone look to deliver vast amounts of vaccines and treatments at large scale - what does the future hold for pharmaceutical manufacturing?
Read case study
Pharma Manufacturing Pain Points: How a clear strategy could be the vaccine your company needs
Working within the pharmaceutical industry, you will know that rapid growth in the market brings with it a number of challenges. We’ve unpacked some of the pharma challenges currently affecting the sector, along with some perfectly prescribed antidotes to fight them.
Read article
The importance of production capacity and strategic planning in pharmaceutical manufacturing
Ongoing development of manufacturing sites is essential to provide future-state readiness of a continually evolving business environment.
Read article
Case Study: Global pharmaceutical company use Access planning scheduling software for pandemic planning
Using Access Orchestrate, Baseline Controls’ consultants were able to conduct a detailed analysis of capacity long before full production had begun. Since Access Orchestrate was first implemented to prove capacity, the pharmaceutical company has scaled up its use of the software across the site for day-to-day production scheduling.
Read case study
Case Study: Major international pharmaceutical company uses Access Planning and Scheduling software to drive strategic initiatives
Pharmaceutical companies using Access Orchestrate as their day-to-day production scheduling and capacity tool are also exploiting its functionality to address key strategic issues.
Read case study
Case Study: Day-to-day production scheduling for international pharmaceutical company
In this case study, we learn how one of the world’s largest pharmaceutical companies is using Access Orchestrate Planning and Scheduling software every day in a production facility producing vaccines and self-injected prescription medicines.
Read case study
Case Study: Greater management, control and visualisation for Surepharm Services
Access Orchestrate helps Surepharm Services with greater management, control and visualisation over orders, which has improved production, as well as heightened morale and collaboration.
Read case study
Efficiency: The Key To Sustainable Manufacturing In Pharma
Terms such as ‘efficiency’ and ‘sustainability’ have long been key talking points for pharma manufacturing. Indeed, in an industry that’s facing increasingly complex pressures, particularly as it adjusts to the changing demands seen as a result of Covid-19, the need for resources and processes that reduce wastage and maximise productivity, profitability and reliability are essential.
Read article
Case Study: Automated Scheduling Set to Reduce Costs and Drive Up Revenue at Major Biopharma Firm
Access Orchestrate helps a major US Biopharma company with greater management, control and visualisation over orders, which has improved production, as well as heightened morale and collaboration.
Read case study